Mónica Guerrero

1.1k total citations
16 papers, 530 citations indexed

About

Mónica Guerrero is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mónica Guerrero has authored 16 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 2 papers in Infectious Diseases and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mónica Guerrero's work include Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Respiratory Support and Mechanisms (9 papers) and Respiratory and Cough-Related Research (3 papers). Mónica Guerrero is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Respiratory Support and Mechanisms (9 papers) and Respiratory and Cough-Related Research (3 papers). Mónica Guerrero collaborates with scholars based in Spain, Italy and Greece. Mónica Guerrero's co-authors include Ernesto Crisafulli, Néstor Soler, Antoní Torres, Arturo Huerta, Rosario Menéndez, Raquel Martínez, Albert Gabarrús, Emilio Bouza, F Parras and Ma Cruz Menárguez and has published in prestigious journals such as PLoS ONE, Scientific Reports and CHEST Journal.

In The Last Decade

Mónica Guerrero

15 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mónica Guerrero Spain 12 347 114 114 71 58 16 530
Laura R. A. Schouten Netherlands 12 417 1.2× 271 2.4× 137 1.2× 33 0.5× 166 2.9× 17 807
Marc Garnier France 11 127 0.4× 242 2.1× 135 1.2× 31 0.4× 42 0.7× 53 732
Allan Pamba Kenya 13 126 0.4× 175 1.5× 77 0.7× 30 0.4× 37 0.6× 18 676
Silvia Terraneo Italy 15 270 0.8× 178 1.6× 57 0.5× 152 2.1× 63 1.1× 36 639
Siu‐Ka Mak China 16 121 0.3× 112 1.0× 101 0.9× 13 0.2× 47 0.8× 39 595
Tomoyoshi Mohri Japan 9 69 0.2× 223 2.0× 83 0.7× 35 0.5× 128 2.2× 13 520
Eleni Mouloudi Greece 15 200 0.6× 175 1.5× 38 0.3× 42 0.6× 21 0.4× 44 662
Beatriz Montull Spain 14 234 0.7× 392 3.4× 46 0.4× 42 0.6× 17 0.3× 24 573
Sabine C A Meijvis Netherlands 14 139 0.4× 432 3.8× 90 0.8× 30 0.4× 48 0.8× 29 724
Marta Albalate Spain 14 69 0.2× 94 0.8× 150 1.3× 16 0.2× 44 0.8× 47 542

Countries citing papers authored by Mónica Guerrero

Since Specialization
Citations

This map shows the geographic impact of Mónica Guerrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Guerrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Guerrero more than expected).

Fields of papers citing papers by Mónica Guerrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Guerrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Guerrero. The network helps show where Mónica Guerrero may publish in the future.

Co-authorship network of co-authors of Mónica Guerrero

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Guerrero. A scholar is included among the top collaborators of Mónica Guerrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Guerrero. Mónica Guerrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Crisafulli, Ernesto, Mónica Guerrero, Adrián Ceccato, et al.. (2020). Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD. Internal and Emergency Medicine. 16(2). 401–408. 13 indexed citations
2.
Crisafulli, Ernesto, Mónica Guerrero, Adrián Ceccato, et al.. (2018). Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis. Scientific Reports. 8(1). 16 indexed citations
3.
Ceccato, Adrián, Mónica Guerrero, Arturo Huerta, et al.. (2018). Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease. Respiratory Research. 19(1). 119–119. 21 indexed citations
4.
Mantero, Marco, Paola Rogliani, Marta Di Pasquale, et al.. (2017). Acute exacerbations of COPD: risk factors for failure and relapse. International Journal of COPD. Volume 12. 2687–2693. 41 indexed citations
5.
Guerrero, Mónica, Ernesto Crisafulli, Adamantia Liapikou, et al.. (2016). Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLoS ONE. 11(3). e0150737–e0150737. 71 indexed citations
6.
Guerrero, Mónica, Arturo Huerta, Néstor Soler, et al.. (2016). Impact of step exercises as an early intervention during COPD exacerbation. PA2061–PA2061.
7.
Crisafulli, Ernesto, Antoní Torres, Arturo Huerta, et al.. (2015). Predicting In-Hospital Treatment Failure (≤7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids. COPD Journal of Chronic Obstructive Pulmonary Disease. 13(1). 82–92. 24 indexed citations
8.
Crisafulli, Ernesto, Arturo Huerta, Raúl Méndez, et al.. (2014). C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. European Respiratory Journal. 44(Suppl 58). P966–P966. 1 indexed citations
9.
Crisafulli, Ernesto, Mónica Guerrero, Rosario Menéndez, et al.. (2014). Inhaled Corticosteroids Do Not Influence the Early Inflammatory Response and Clinical Presentation of Hospitalized Subjects With COPD Exacerbation. Respiratory Care. 59(10). 1550–1559. 16 indexed citations
10.
Huerta, Arturo, Néstor Soler, Mariano Esperatti, et al.. (2014). Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respiratory Research. 15(1). 17–17. 46 indexed citations
11.
Crisafulli, Ernesto, Antoní Torres, Arturo Huerta, et al.. (2014). C-Reactive Protein at Discharge, Diabetes Mellitus and ≥1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 12(3). 311–320. 28 indexed citations
12.
Huerta, Arturo, Ernesto Crisafulli, Rosario Menéndez, et al.. (2013). Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics. 42. 2068. 3 indexed citations
13.
Huerta, Arturo, Ernesto Crisafulli, Rosario Menéndez, et al.. (2013). Pneumonic and Nonpneumonic Exacerbations of COPD. CHEST Journal. 144(4). 1134–1142. 86 indexed citations
14.
Sialer, Salvador, Adamantia Liapikou, Mónica Guerrero, & Antoní Torres. (2012). Relation Between Chronic Obstructive Pulmonary Disease and Antibiotics. Current Infectious Disease Reports. 14(3). 300–307. 6 indexed citations
15.
Carreras, Enric, Francesc Fernández‐Avilés, Mónica Guerrero, et al.. (2010). Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplantation. 45(9). 1417–1422. 62 indexed citations
16.
Parras, F, Mónica Guerrero, Emilio Bouza, et al.. (1995). Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 39(1). 175–179. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026